| |
| |
|
| Insider
Information: |
Corin Denis |
| Relationship: |
Chief Executive Office... |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
5,036,335 |
|
|
Indirect Shares
|
135,300 |
|
|
| Direct
Value |
$9,530,249 |
|
|
|
Indirect Value
|
$538,494 |
|
|
| Total
Shares |
5,171,635 |
|
|
| Total
Value |
$10,068,743 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Marker Therapeutics Inc |
MRKR |
President, Director |
2012-02-17 |
2,394,535 |
2011-03-23 |
135,300 |
Premium* |
|
|
Q Biomed Inc. |
QBIO |
Chief Executive Office... |
2022-05-26 |
2,641,800 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2022-05-26 |
4 |
A |
$20,000.00 |
$2,147,483,647 |
D/D |
200,000 |
2,641,800 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-12 |
4 |
S |
$2.11 |
$13,530 |
D/D |
(6,400) |
2,435,400 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-10 |
4 |
AS |
$2.85 |
$19,934 |
D/D |
(7,000) |
2,441,800 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-09 |
4 |
AS |
$3.37 |
$23,578 |
D/D |
(7,000) |
2,448,800 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-06 |
4 |
AS |
$3.58 |
$24,690 |
D/D |
(6,900) |
2,455,800 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-05 |
4 |
AS |
$3.54 |
$23,342 |
D/D |
(6,600) |
2,462,700 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-03 |
4 |
AS |
$3.46 |
$7,610 |
D/D |
(2,200) |
2,469,300 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-07-02 |
4 |
AS |
$3.42 |
$6,836 |
D/D |
(2,000) |
2,471,500 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-29 |
4 |
AS |
$3.40 |
$7,138 |
D/D |
(2,100) |
2,473,500 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-28 |
4 |
AS |
$3.39 |
$17,961 |
D/D |
(5,300) |
2,475,600 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-27 |
4 |
AS |
$3.44 |
$16,833 |
D/D |
(4,900) |
2,480,900 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-26 |
4 |
AS |
$3.43 |
$13,033 |
D/D |
(3,800) |
2,485,800 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-25 |
4 |
AS |
$3.42 |
$4,785 |
D/D |
(1,400) |
2,489,600 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-21 |
4 |
S |
$3.45 |
$11,388 |
D/D |
(3,300) |
2,491,000 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive Officer |
• • • |
2018-06-21 |
4 |
AS |
$3.47 |
$19,765 |
D/D |
(5,700) |
2,494,300 |
0 |
- |
|
| QBIO |
Q Biomed Inc. |
Chief Executive OfficerOfficer |
• • • |
2015-04-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500,000 |
|
- |
|
| MRKR |
Marker Therapeutics Inc |
President |
• • – |
2012-02-17 |
4 |
A |
$0.15 |
$25,000 |
D/D |
166,667 |
2,394,535 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
President and CFO |
• • – |
2011-03-23 |
4 |
S |
$0.12 |
$19,200 |
I/I |
(160,000) |
135,300 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
President and CFO |
• • – |
2011-03-23 |
4 |
A |
$0.17 |
$50,000 |
D/D |
294,118 |
2,227,868 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
President |
• • – |
2009-06-29 |
4 |
A |
$0.10 |
$29,530 |
I/I |
295,300 |
295,300 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
President |
• • – |
2009-06-29 |
4 |
A |
$0.10 |
$192,575 |
D/D |
1,925,750 |
1,933,750 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
President and CEOOfficer |
• – – |
2007-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
110,000 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
